# Methylnaltrexone for Treatment of Opiate-Induced Constipation in the Intensive Care Unit

> **NCT01050595** · PHASE3 · UNKNOWN · sponsor: **St. John Health System, Michigan** · enrollment: 80 (estimated)

## Conditions studied

- Opioid-induced Constipation

## Interventions

- **DRUG:** Methylnaltrexone Bromide
- **DRUG:** Placebo-Normal Saline

## Key facts

- **NCT ID:** NCT01050595
- **Lead sponsor:** St. John Health System, Michigan
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-12
- **Primary completion:** 2010-10
- **Final completion:** 2010-12
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2010-01-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01050595

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01050595, "Methylnaltrexone for Treatment of Opiate-Induced Constipation in the Intensive Care Unit". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01050595. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*